Tocilizumab treatment

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire Dijon

Conditions

Giant Cell Arteritis

Phase 3

MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial

Active, not recruitingNCT03892785

Centre Hospitalier Universitaire DijonGiant Cell Arteritis

Start: 2020-01-27End: 2027-01-01Updated: 2026-04-24

TocilizuMab discontinuAtion in GIant Cell Arteritis

Active, not recruitingNCT06037460

Centre Hospitalier Universitaire DijonGiant Cell Arteritis

Start: 2024-05-13End: 2028-11-01Updated: 2026-05-04

Related Papers

Immediate versus gradual Tocilizu<b>M</b>ab discontinuAtion in G<b>I</b>ant Cell Arteritis: protocol of the multicentre randomised open-label MAGICA trial.

2025-10-09